BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1388572)

  • 1. Prediction of recurrence in giant cell bone tumors by DNA cytometry.
    Sun D; Biesterfeld S; Adler CP; Böcking A
    Anal Quant Cytol Histol; 1992 Aug; 14(4):341-6. PubMed ID: 1388572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative pathological study of aggressiveness of giant cell tumor of bone.
    Sun DQ; Feng CH; Fang JQ; Biesterfeld S; Boecking A
    Chin Med J (Engl); 1991 Apr; 104(4):281-7. PubMed ID: 2065544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation index and vascular density of giant cell tumors of bone: are they prognostic markers?
    Sulh MA; Greco MA; Jiang T; Goswami SB; Present D; Steiner G
    Cancer; 1996 May; 77(10):2044-51. PubMed ID: 8640668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Giant cell tumor of bone. Morphological, immunohistochemical, morphometric and DNA flow cytometric findings].
    Kröber SM; Greschniok A; Böhm P; Kaiserling E
    Verh Dtsch Ges Pathol; 1998; 82():279-83. PubMed ID: 10095447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
    Gouin F; Dumaine V;
    Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
    ; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
    J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Giant cell tumours of bone. A DNA-flow cytometric study.
    Heliö H; Karaharju E; Böhling T; Nordling S
    Eur J Surg Oncol; 1994 Jun; 20(3):200-6. PubMed ID: 8181593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell tumor of bone. A clinicopathologic and DNA flow cytometric analysis.
    Sara AS; Ayala AG; el-Naggar A; Ro JY; Raymond AK; Murray JA
    Cancer; 1990 Nov; 66(10):2186-90. PubMed ID: 2224773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metastases: prognostic applications of cytometric DNA analysis.
    Herget GW; Smolka W; Adler CP; Uhl M; Kreuz PC; Knoller SM
    Anal Quant Cytol Histol; 2004 Aug; 26(4):217-22. PubMed ID: 15457674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between surgical staging, pathologic grading, operative type and postoperative recurrence in giant cell tumor of bone].
    Dong Z; Long M; Li H; Fu Y; Chen H
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):174-6. PubMed ID: 11938783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell tumors of bone: nonsurgical factors associated with local recurrence.
    Teixeira LE; Vilela JC; Miranda RH; Gomes AH; Costa FA; de Faria VC
    Acta Orthop Traumatol Turc; 2014; 48(2):136-40. PubMed ID: 24747619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up study of giant cell tumor of bone.
    Takechi H; Ito S; Taguchi K
    Acta Med Okayama; 1982 Oct; 36(5):349-60. PubMed ID: 7180571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intralesional treatment of giant cell tumor of the distal radius comparable to resection with respect to local control and functional outcome?
    Wysocki RW; Soni E; Virkus WW; Scarborough MT; Leurgans SE; Gitelis S
    Clin Orthop Relat Res; 2015 Feb; 473(2):706-15. PubMed ID: 25472928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of giant cell tumor of bone--a report of 50 cases].
    Zhou JW
    Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):389-91. PubMed ID: 2276336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent pulmonary metastases from benign giant cell tumors of the bone: report of two cases and analysis of nuclear DNA content by flow cytometry.
    Takanami I; Imamura T; Morota N; Kodaira S
    Surg Today; 1994; 24(5):476-80. PubMed ID: 8054822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soft-tissue recurrence of giant-cell tumor of bone after irradiation and excision.
    Riley LH; Hartmann WH; Robinson RA
    J Bone Joint Surg Am; 1967 Mar; 49(2):365-8. PubMed ID: 6019373
    [No Abstract]   [Full Text] [Related]  

  • 19. Giant cell tumors treated by curettage.
    Urban K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1986; 29(4-5):427-42. PubMed ID: 3481649
    [No Abstract]   [Full Text] [Related]  

  • 20. Giant cell tumour of hyoid bone: case report.
    Iype EM; Abraham EK; Kumar K; Pandey M; Prabhakar J; Ahamed MI; Sebastian P
    Br J Oral Maxillofac Surg; 2000 Dec; 38(6):610-611. PubMed ID: 11092777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.